Minimally Invasive Surgical (Mis) Device Market Size by Types (Handheld Instruments, Electrosurgical Instruments, Guiding Devices), By Applications Covered (Cardiothoracic Surgery, Gastrointestinal Surgery, Orthopedic Surgery) and Regional Forecast to 2033

Minimally Invasive Surgical (Mis) Device Market Size

The Global Minimally Invasive Surgical (MIS) Device market size was USD 52.23 billion in 2024 and is expected to reach USD 55.44 billion in 2025, advancing to USD 89.3 billion by 2033, exhibiting a CAGR of 6.14% during the forecast period [2025-2033]. Increasing preference for less invasive procedures, reduced hospital stays, and advancements in surgical instruments are fueling global demand.

The US Minimally Invasive Surgical (MIS) Device market was valued at USD 27.18 billion in 2025, accounting for approximately 49% of the global share, supported by a high volume of surgeries, strong healthcare infrastructure, and rapid adoption of robotic-assisted technologies.

Key Findings

• Market Size – Valued at USD 55.44 billion in 2025, expected to reach USD 89.3 billion by 2033, growing at a CAGR of 6.14%.

• Growth Drivers – 42% rise in robotic-assisted surgeries, 35% increase in hospital MIS budgets, 28% growth in AI-assisted navigation usage.

• Trends – 40% surge in modular robotic system adoption, 30% growth in disposable MIS instruments, 25% increase in ergonomic handheld device sales.

• Key Players – Ethicon Endo-Surgery, Inc., Human Extensions LTD, DistalMotion, Actuated Medical, Inc., Fortimedix B.V.

• Regional Insights – North America 42% share, Europe 25%, Asia-Pacific 28%, Middle East & Africa 5%, with Asia-Pacific showing fastest adoption growth.

• Challenges – 50% of smaller hospitals face high capital cost barriers, 30% underutilization of robotic systems, 25% shortage of trained MIS surgeons.

• Industry Impact – 45% reduction in hospital stay duration, 35% improvement in surgical accuracy, 20% decrease in post-surgical complication rates.

• Recent Developments – 45% faster instrument changeover, 30% reduced infection risk, 25% improved surgical navigation accuracy.

The Minimally Invasive Surgical (MIS) Device market encompasses a broad range of instruments—including laparoscopic tools, endoscopes, robotic-assisted systems and visualization platforms—specifically engineered to enable surgeries through small incisions. The global MIS Device market is underpinned by the increasing number of minimally invasive procedures, which now represent close to 70 % of all surgeries worldwide . Demand is robust across specialties such as general surgery, gynecology, urology, orthopedics and cardiovascular surgery. Hospitals and ambulatory surgical centers prioritize MIS Devices to reduce operative trauma, shorten hospital stays and boost patient throughput. Advances in imaging, robotics and disposable instrument technologies are enabling more precise, versatile and infection‑resistant MIS Devices.

Minimally Invasive Surgical (MIS) Device Market Trends

The Minimally Invasive Surgical (MIS) Device market is witnessing a rapid proliferation of robotic-assisted systems. For instance, robotic surgery now comprises over 70 % of the total surgical robotics market value, with key players like Intuitive Surgical dominating capital equipment sales and driving consumables uptake (approximately 70 % of MIS device volume). Global da Vinci procedures rose by about 18 % in Q4 2024, totaling roughly 2.68 million procedures, with further expected increases of 13–16 % through 2025. Over 15 million laparoscopic procedures are performed annually across the globe, increasing at roughly 1 % per year. In U.S. inpatient major operating room settings, MIS procedures accounted for about 11 % of surgeries in 2017–2018, with robotic-assisted cases rising from 2.5 % to 2.9 % in that period. Ambulatory MIS procedures rose from 16.9 % to 18 % between 2016 and 2018 . Hybrid approaches combining laparoscopy with open or robotic elements are expanding, while disposable MIS Devices are gaining momentum as infection control becomes critical. Outpatient surgical settings are driving demand for portable, cost‑effective devices. Finally, regulatory approvals across new applications—and surgeon training programs—are facilitating broader adoption of MIS Devices across regions.

Minimally Invasive Surgical (MIS) Device Market Dynamics

The Minimally Invasive Surgical (MIS) Device market is shaped by several intersecting dynamics. Technological innovations in surgical robotics, AI‑enabled imaging, 3D visualization and micro‑instrumentation are elevating the precision and range of MIS Devices available. Rising global prevalence of chronic diseases, aging populations, and elective procedure volumes are driving increased use of MIS Devices across specialties. General surgery institutions, ambulatory surgery centers and teaching hospitals are transitioning from traditional open procedures to MIS, drawn by faster recovery and lower post‑operative complication rates. Robotic systems are increasingly deployed for complex laparoscopic procedures like hernia repairs (e.g. TAPP, TEP, eTEP), bariatric, urological and orthopedic surgeries. The expansion of outpatient surgical volume is boosting demand for compact, user‑friendly MIS Devices. Manufacturers continue investing in R&D to enhance device integration, robotics precision, instrument disposables and AI support—creating a dynamic environment of innovation and clinical transformation.

OPPORTUNITY

"Outpatient Expansion and Emerging Markets"

Growth in outpatient surgical centers and emerging markets presents strong opportunities for Minimally Invasive Surgical (MIS) Device manufacturers. The share of MIS procedures performed in ambulatory settings rose from 16.9 % in 2016 to 18 % by 2018 in the U.S. alone. Meanwhile, emerging regions such as Asia-Pacific and LAMEA are witnessing rapid expansion of MIS adoption owing to rising healthcare access, increasing chronic disease incidence, and healthcare infrastructure investments . In the Asia-Pacific region, minimally invasive surgery procedures are growing fastest, driven by large population bases in India and China, surging elective surgery rates, and technology uptake in hospitals. Robotic systems with modular designs (like Versius) are gaining regulatory approvals and offering lower‑cost alternatives to incumbents—creating opportunity for affordable MIS Devices in mid‑market institutions . Continued expansion of training programs, remote surgery, and disposable device offerings further enhance access and uptake of Minimally Invasive Surgical (MIS) Device solutions.

DRIVERS

"Technological Innovation and Rising Surgical Volumes"

The rapid evolution of surgical technology is a key driver of growth in the Minimally Invasive Surgical (MIS) Device market. Global adoption of robotic-assisted systems now accounts for more than 70 % of surgical robotics market value, stimulating demand for instrument disposables which constitute around 70 % of MIS device volume. In 2024, da Vinci-guided surgeries reached nearly 2.68 million procedures per year, marking an 18 % rise and reflecting rising global adoption. Meanwhile, over 15 million laparoscopic procedures are conducted worldwide annually, increasing at approximately 1 % per year. These numbers highlight surging procedural volume, fueling demand for elements—trocar systems, scopes, instrumentation and visualization devices—of the Minimally Invasive Surgical (MIS) Device ecosystem.

Market Restraints

Market Challenges

Escalating costs, limited access, and under-utilization of Minimally Invasive Surgical (MIS) Device technology continue to hamper broader adoption. In India, only 220 robotic systems are installed across over 70,000 hospitals, highlighting infrastructure gaps even as awareness rises. In the UK, NHS data shows some trusts use surgical robots less than once per week and under‑utilize scanners and advanced MIS Devices despite high upfront investment . In addition, maintenance, training programs, and credentialing impose significant operational burden. Small and rural facilities often lack funding or skilled staff to operate devices like robotic platforms. High per‑procedure disposables and the risk of idle equipment reduce ROI, discouraging expansion. This combination of financial, logistical and utilization barriers constitutes a major challenge in MIS Device market growth.

Segmentation Analysis

The Minimally Invasive Surgical (MIS) Device market is segmented both by device type and surgical application, reflecting diverse clinical needs. On the device side, key categories such as handheld instruments, electrosurgical devices, guiding devices and inflation systems fulfill different procedural roles. Surgical centers adopt instruments tailored to specialties like cardiothoracic, orthopedic, gastrointestinal, urological and gynecological procedures. Distribution of type and application segments often depends on procedure frequency and region: handheld instruments dominate in high‑volume settings, while robotic-guided or inflation devices are prioritized in complex or high‑risk surgeries. Allocation between hospital and ambulatory surgery centers also influences segmentation: portable inflation systems find increasing adoption in outpatient settings. This segmentation supports focused marketing, product development, and sales strategies aligned to clinical practice patterns.

By Type

• Handheld Instruments: Handheld instruments such as graspers, retractors and suturing tools accounted for the largest share of the MIS Device market—about USD 6–7 billion in 2023—to meet high volumes of laparoscopic and basic procedures in general surgery and gynecology. This segment maintains prominence due to ubiquity across procedures and lower complexity, enabling rapid adoption in both hospitals and ambulatory surgical centers.

• Electrosurgical Instruments: Electrosurgical devices—used for cutting, coagulating or tissue removal—represent the most lucrative segment with fastest growth among MIS types. These instruments offer energy-based precision and are essential in complex minimally invasive procedures like oncology resections and hemostasis control.

• Guiding Devices: Guiding devices, including scopes, trocars and endoscopic navigation platforms, constitute an integral support segment for visualization within MIS Device systems. These devices enhance surgical accuracy across specialties and are critical in image-guided procedures and robotic systems.

• Inflation Systems: Inflation systems (e.g. insufflators) support MIS Implantation by creating working space within body cavities during laparoscopy or thoracoscopy. These systems are especially prevalent in abdominal and bariatric surgeries, bolstered by growing volumes of gastrointestinal procedures globally.

By Application

• Cardiothoracic Surgery: Minimally Invasive Surgical (MIS) Devices in cardiothoracic applications include endoscopic and robotic tools for valve repair, bypass grafting and thoracoscopic lung procedures. Demand is rising for transcatheter therapies like TAVR and TMTT, which utilize MIS platforms and contribute billions in sales (e.g. Edwards Lifesciences transcatheter valve range reaching USD 4.1–4.4 billion in sales).

• Cosmetic / Bariatric Surgery: In bariatric and cosmetic surgery, MIS Devices like laparoscopic staplers, trocars and electrosurgical scalpels enable sleeve gastrectomy and liposuction with reduced scarring and hospital stay. These procedures account for a growing share of MIS Device usage globally, particularly in countries with rising obesity rates.

• Gastrointestinal Surgery: Gastrointestinal applications leverage MIS Devices for colon resections, gallbladder removals, hernia repairs and appendectomies. Over 15 million laparoscopic procedures are performed annually worldwide, many powered by handheld instruments and inflation systems.

• Orthopedic Surgery: Orthopedic minimally invasive procedures—including arthroscopy, spine decompression and joint repair—accounted for around 24–25 % of MIS Device application share in 2024. Handheld and electrosurgical devices, combined with guidance platforms, are widely deployed in this segment.

• Gynecological Surgery: Applications in gynecology such as hysterectomy, myomectomy and endometriosis surgery rely heavily on MIS Devices. Electrosurgical instruments and handheld laparoscopic tools facilitate outpatient and day‑case procedures, minimizing recovery time.

• Vascular Surgery: Vascular MIS procedures—like endovascular aneurysm repair (EVAR), peripheral angioplasty and venous treatments—use guiding devices and inflation systems extensively, with benefits of reduced incision trauma and shorter hospital stay.

• Urological Surgery: Urological applications—prostatectomy, cystectomy and kidney stone removal—often utilize robotic platforms and electrosurgical instruments. Devices like NanoKnife are FDA-approved for irreversible electroporation in prostate cancer, offering precision with nerve-sparing outcomes and rising uptake in oncology centers.

• Others: Other MIS Device applications include neurosurgery, otolaryngology and ENT procedures, where miniaturized endoscopes, handheld and guiding tools are enabling less invasive interventions with improved patient outcomes.

Minimally Invasive Surgical (MIS) Device Market Regional Outlook

North America held the largest share of the Minimally Invasive Surgical (MIS) Device market in recent years—accounting for around 40–42 % of global market value in 2024—driven by advanced healthcare infrastructure, high surgical volumes and strong reimbursement for MIS procedures . The U.S. alone generated over USD 7.6–8.3 billion from instruments like handheld and electrosurgical devices in 2023–2024. Asia-Pacific regions, particularly China and India, are emerging as the fastest-growing MIS Device markets, supported by rising chronic disease prevalence, surgical capacity expansion, and healthcare investment; China’s instrument market is projected at USD 6.7 billion by 2030. Europe and Canada follow with stable growth trajectories, while Middle East, Latin America and Africa currently represent smaller but increasing shares due to expanding hospital infrastructure and growing adoption of MIS Devices across urban tertiary centers.

North America

North America holds about 42% of the global Minimally Invasive Surgical (MIS) Device market share. The United States dominates the region with approximately 85% share, driven by high adoption of robotic-assisted systems, laparoscopic tools, and advanced visualization devices across hospitals and ambulatory surgical centers. Canada accounts for nearly 10% of the market, with significant use of handheld instruments and electrosurgical devices in orthopedic and gynecological surgeries. Mexico contributes around 5%, with growth driven by the expansion of private healthcare facilities and an increasing number of minimally invasive bariatric and gastrointestinal surgeries. Strong healthcare infrastructure and skilled workforce support the region’s leadership.

Europe

Europe represents around 25% of the global Minimally Invasive Surgical (MIS) Device market share. Germany leads with about 28% share in the region, supported by a high number of specialized surgical centers and early adoption of robotic platforms. France holds nearly 20% of the European market, driven by strong investments in hospital modernization and advanced laparoscopic equipment. The United Kingdom contributes approximately 15%, with rising adoption of disposable MIS devices and hybrid surgical techniques. Other countries such as Italy and Spain also show strong demand, particularly in bariatric, gynecological, and gastrointestinal surgery segments.

Asia-Pacific

Asia-Pacific accounts for roughly 28% of the global Minimally Invasive Surgical (MIS) Device market share, making it one of the fastest-growing regions. China dominates with about 40% of the regional share, driven by government healthcare investments, a large patient base, and rapid adoption of robotic-assisted systems in urban hospitals. Japan holds approximately 25% share, with strong demand in cardiothoracic, orthopedic, and gastrointestinal procedures. India contributes around 15%, supported by growing medical tourism and increased availability of advanced laparoscopic instruments in metropolitan cities. Other markets like South Korea and Australia are also expanding rapidly with enhanced surgical infrastructure.

Middle East & Africa

The Middle East & Africa region holds about 5% of the global Minimally Invasive Surgical (MIS) Device market share. The United Arab Emirates leads with nearly 30% of the regional share, supported by advanced private healthcare facilities and adoption of robotic surgery in high-end hospitals. Saudi Arabia follows with around 25% share, focusing on upgrading hospital surgical capabilities and training programs. South Africa accounts for roughly 20% share, with laparoscopic procedures being the primary application. Other countries in the region are gradually adopting MIS devices as healthcare access and infrastructure improve, especially in urban and economically developed areas.

List of Key Minimally Invasive Surgical (MIS) Device Market Companies Profiled

Investment Analysis and Opportunities

The Minimally Invasive Surgical (MIS) Device market presents strong investment opportunities driven by technological advancements, expanding applications, and rising surgical volumes. Private equity and venture capital firms are actively funding robotic-assisted systems, with multiple funding rounds exceeding 50% growth in investment size over the past two years. Hospital procurement budgets for MIS Devices have increased by approximately 35% in advanced economies, reflecting a shift from traditional surgery equipment to minimally invasive platforms. Emerging markets like Asia-Pacific and Latin America are experiencing over 40% growth in public-private partnerships aimed at upgrading surgical infrastructure. Additionally, the market for disposable MIS instruments is expanding rapidly, with adoption rates growing by around 30% due to infection control policies. Investors are targeting companies with strong R&D pipelines, modular robotic systems, and AI-driven surgical assistance tools, which are expected to see adoption increases of more than 25% year-over-year. Government healthcare modernization programs in regions such as the Middle East are also allocating over 20% of infrastructure budgets to MIS-related equipment, signaling sustained growth potential. The shift towards outpatient and day-care surgeries, which now account for more than 45% of MIS procedures, is further enhancing investment prospects across multiple geographies.

NEW PRODUCTS Development

In recent years, product development in the Minimally Invasive Surgical (MIS) Device market has accelerated, with companies launching advanced systems targeting precision, speed, and patient safety. Robotic platforms with modular designs have seen adoption growth exceeding 40%, offering hospitals customizable configurations for different surgical specialties. Innovations in 3D visualization and augmented reality integration have increased surgeon training efficiency by over 35%, improving procedural accuracy. Disposable electrosurgical instruments have witnessed more than 30% penetration growth in infection-sensitive surgical environments. Additionally, AI-assisted navigation systems, used for real-time surgical mapping, have experienced a 28% rise in adoption. Manufacturers are increasingly focusing on eco-friendly and recyclable device components, responding to sustainability demands that influence over 20% of purchasing decisions. Handheld devices with ergonomic designs have gained popularity, with sales volumes increasing by 25% in the last two years. Inflation systems with improved flow control technology have reduced procedural time by up to 15%, directly impacting surgical throughput. Collectively, these innovations are expanding the scope of MIS procedures and increasing the competitive edge of market leaders.

Recent Developments by Manufacturers in Minimally Invasive Surgical (MIS) Device Market

1. Launch of modular robotic MIS system with 45% faster instrument changeover.

2. Introduction of disposable laparoscopic stapler achieving 30% reduced infection risk.

3. FDA clearance for AI-powered surgical navigation tool improving accuracy by 25%.

4. Partnership to develop eco-friendly MIS instrument line with 20% lower carbon footprint.

5. Expansion of production capacity for handheld laparoscopic instruments by 35% to meet rising demand.

REPORT COVERAGE of Minimally Invasive Surgical (MIS) Device Market

The report on the Minimally Invasive Surgical (MIS) Device market offers an in-depth analysis of market trends, segmentation, regional insights, and competitive dynamics. It covers product categories such as handheld instruments, electrosurgical devices, guiding systems, and inflation units, along with applications spanning cardiothoracic, orthopedic, gastrointestinal, gynecological, urological, vascular, and other surgeries. The report examines demand distribution across major regions, highlighting North America’s 42% share, Europe’s 25%, Asia-Pacific’s 28%, and Middle East & Africa’s 5%. Key market drivers, including technological advancements and rising outpatient procedures, are detailed alongside restraints like high equipment costs and access barriers. Opportunities in emerging markets, outpatient expansions, and modular robotic designs are explored with supporting facts and figures. The competitive landscape section profiles leading companies, noting their market positioning and innovations. Additionally, the report reviews investment flows, funding trends, and the role of public-private partnerships in shaping the market’s trajectory. It also includes analysis of recent product launches, FDA approvals, and R&D focus areas, giving stakeholders a comprehensive view of the current and future state of the Minimally Invasive Surgical (MIS) Device industry.